Gut-brain Axis and migraine headache: a comprehensive review

Mahsa Arzani, Soodeh Razeghi Jahromi, Zeinab Ghorbani, Fahimeh Vahabizad, Paolo Martelletti, Amir Ghaemi, Simona Sacco, Mansoureh Togha, School of Advanced Studies of the European Headache Federation (EHF-SAS), Mahsa Arzani, Soodeh Razeghi Jahromi, Zeinab Ghorbani, Fahimeh Vahabizad, Paolo Martelletti, Amir Ghaemi, Simona Sacco, Mansoureh Togha, School of Advanced Studies of the European Headache Federation (EHF-SAS)

Abstract

The terminology "gut-brain axis "points out a bidirectional relationship between the GI system and the central nervous system (CNS). To date, several researches have shown that migraine is associated with some gastrointestinal (GI) disorders such as Helicobacter pylori (HP) infection, irritable bowel syndrome (IBS), and celiac disease (CD). The present review article aims to discuss the direct and indirect evidence suggesting relationships between migraine and the gut-brain axis. However, the mechanisms explaining how the gut and the brain may interact in patients with migraine are not entirely clear. Studies suggest that this interaction seems to be influenced by multiple factors such as inflammatory mediators (IL-1β, IL-6, IL-8, and TNF-α), gut microbiota profile, neuropeptides and serotonin pathway, stress hormones and nutritional substances. Neuropeptides including CGRP, SP, VIP, NPY are thought to have antimicrobial impact on a variety of the gut bacterial strains and thus speculated to be involved in the bidirectional relationship between the gut and the brain. According to the current knowledge, migraine headache in patients harboring HP might be improved following the bacteria eradication. Migraineurs with long headache history and high headache frequency have a higher chance of being diagnosed with IBS. IBS and migraine share some similarities and can alter gut microflora composition and thereby may affect the gut-brain axis and inflammatory status. Migraine has been also associated with CD and the condition should be searched particularly in patients with migraine with occipital and parieto-occipital calcification at brain neuroimaging. In those patients, gluten-free diet can also be effective in reducing migraine frequency. It has also been proposed that migraine may be improved by dietary approaches with beneficial effects on gut microbiota and gut-brain axis including appropriate consumption of fiber per day, adhering to a low glycemic index diet, supplementation with vitamin D, omega-3 and probiotics as well as weight loss dietary plans for overweight and obese patients.

Conflict of interest statement

There is no conflict of interest.

Figures

Fig. 1
Fig. 1
Gut -Brain Axis. CNS, Central nervous system; ENS, Enteric nervous system; GI, Gastrointestinal
Fig. 2
Fig. 2
Mechanisms of the effects of gut bacteria in keeping normal balance of gut-brain axis via indirect signaling. CGRP, Calcitonin gene-related peptide; CRH, Corticotrophin-releasing hormone; HPA, Hypothalamic pituitary adrenal axis; LPS, lipopolysaccharides; IL, Interleukin; TNFa, Tumor necrosis factor alpha

References

    1. Stovner LJ, Nichols E, Steiner TJ, Abd-Allah F, Abdelalim A, Al-Raddadi RM, et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the global burden of disease study 2016. The Lancet Neurology. 2018;17(11):954–976. doi: 10.1016/S1474-4422(18)30322-3.
    1. Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain. 2016;17(1):104. doi: 10.1186/s10194-016-0699-5.
    1. Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain. 2018;19(1):17. doi: 10.1186/s10194-018-0846-2.
    1. Dodick DW. A phase-by-phase review of migraine pathophysiology. Headache. 2018;58(Suppl 1):4–16. doi: 10.1111/head.13300.
    1. Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015;125(3):926–938. doi: 10.1172/JCI76304.
    1. Hindiyeh N, Aurora SK. What the gut can teach us about migraine. Curr Pain Headache Rep. 2015;19(7):33. doi: 10.1007/s11916-015-0501-4.
    1. Asano Y, Hiramoto T, Nishino R, Aiba Y, Kimura T, Yoshihara K, et al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol. 2012;303(11):G1288–G1295. doi: 10.1152/ajpgi.00341.2012.
    1. Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. Gamma-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012;113(2):411–417. doi: 10.1111/j.1365-2672.2012.05344.x.
    1. Cavaillon JM. Pro- versus anti-inflammatory cytokines: myth or reality. Cellular and molecular biology (Noisy-le-Grand, France). 2001;47(4):695–702
    1. Murphy SF, Schaeffer AJ, Thumbikat P. Immune mediators of chronic pelvic pain syndrome. Nature reviews Urology. 2014;11(5):259–269. doi: 10.1038/nrurol.2014.63.
    1. Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev. 2005;49(1):65–76. doi: 10.1016/j.brainresrev.2004.11.006.
    1. Ramachandran R. Neurogenic inflammation and its role in migraine. Semin Immunopathol. 2018;40(3):301–314. doi: 10.1007/s00281-018-0676-y.
    1. O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015;277:32–48. doi: 10.1016/j.bbr.2014.07.027.
    1. Amaral FA, Sachs D, Costa VV, Fagundes CT, Cisalpino D, Cunha TM, et al. Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A. 2008;105(6):2193–2197. doi: 10.1073/pnas.0711891105.
    1. Holzer P, Farzi A. Neuropeptides and the microbiota-gut-brain axis. Microbial endocrinology: The microbiota-gut-brain axis in health and disease: Springer; 2014. p. 195–219
    1. Maqsood R, Stone TW. The gut-brain Axis, BDNF. NMDA and CNS Disorders Neurochem Res. 2016;41(11):2819–2835. doi: 10.1007/s11064-016-2039-1.
    1. Wang HX, Wang YP. Gut microbiota-brain Axis. Chin Med J. 2016;129(19):2373–2380. doi: 10.4103/0366-6999.190667.
    1. Camara-Lemarroy CR, Rodriguez-Gutierrez R, Monreal-Robles R, Marfil-Rivera A. Gastrointestinal disorders associated with migraine: a comprehensive review. World J Gastroenterol. 2016;22(36):8149–8160. doi: 10.3748/wjg.v22.i36.8149.
    1. van Hemert S, Breedveld AC, Rovers JM, Vermeiden JP, Witteman BJ, Smits MG, et al. Migraine associated with gastrointestinal disorders: review of the literature and clinical implications. Front Neurol. 2014;5:241.
    1. Galland L. The gut microbiome and the brain. J Med Food. 2014;17(12):1261–1272. doi: 10.1089/jmf.2014.7000.
    1. Farzi A, Frohlich EE, Holzer P. Gut microbiota and the neuroendocrine system. Neurotherapeutics. 2018;15(1):5–22. doi: 10.1007/s13311-017-0600-5.
    1. Petrella C, Giuli C, Agostini S, Bacquie V, Zinni M, Theodorou V, et al. Maternal exposure to low levels of corticosterone during lactation protects against experimental inflammatory colitis-induced damage in adult rat offspring. PLoS One. 2014;9(11):e113389. doi: 10.1371/journal.pone.0113389.
    1. Amini-Khoei H, Haghani-Samani E, Beigi M, Soltani A, Mobini GR, Balali-Dehkordi S, et al. On the role of corticosterone in behavioral disorders, microbiota composition alteration and neuroimmune response in adult male mice subjected to maternal separation stress. Int Immunopharmacol. 2019;66:242–250. doi: 10.1016/j.intimp.2018.11.037.
    1. Verdú EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut. 2006;55(2):182–190. doi: 10.1136/gut.2005.066100.
    1. Lenz HJ, Mortrud MT, Rivier JE, Brown MR. Calcitonin gene related peptide inhibits basal, pentagastrin, histamine, and bethanecol stimulated gastric acid secretion. Gut. 1985;26(6):550–555. doi: 10.1136/gut.26.6.550.
    1. Tache Y, Pappas T, Lauffenburger M, Goto Y, Walsh JH, Debas H. Calcitonin gene-related peptide: potent peripheral inhibitor of gastric acid secretion in rats and dogs. Gastroenterology. 1984;87(2):344–349. doi: 10.1016/0016-5085(84)90711-X.
    1. Li Y, Jiang YC, Owyang C. Central CGRP inhibits pancreatic enzyme secretion by modulation of vagal parasympathetic outflow. Am J Phys. 1998;275(5):G957–G963.
    1. Sandhu KV, Sherwin E, Schellekens H, Stanton C, Dinan TG, Cryan JF. Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Transl Res. 2017;179:223–244. doi: 10.1016/j.trsl.2016.10.002.
    1. Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res. 2007;61(1):37–41. doi: 10.1203/01.pdr.0000250014.92242.f3.
    1. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig Dis Sci. 2012;57(8):2096–2102. doi: 10.1007/s10620-012-2167-7.
    1. Park J, Floch MH. Prebiotics, probiotics, and dietary Fiber in gastrointestinal disease. Gastroenterol Clin N Am. 2007;36(1):47–63. doi: 10.1016/j.gtc.2007.03.001.
    1. Noble EE, Hsu TM, Kanoski SE. Gut to brain Dysbiosis: mechanisms linking Western diet consumption, the microbiome, and cognitive impairment. Front Behav Neurosci. 2017;11:9. doi: 10.3389/fnbeh.2017.00009.
    1. Albenberg LG, Wu GD. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology. 2014;146(6):1564–1572. doi: 10.1053/j.gastro.2014.01.058.
    1. Li H, Li T, Beasley DE, Heděnec P, Xiao Z, Zhang S, et al. Diet diversity is associated with beta but not alpha diversity of pika gut microbiota. Front Microbiol. 2016;7:1169.
    1. Parnell JA, Reimer RA. Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes. 2012;3(1):29–34. doi: 10.4161/gmic.19246.
    1. Marchiando AM, Graham WV, Turner JR. Epithelial barriers in homeostasis and disease. Annu Rev Pathol. 2010;5:119–144. doi: 10.1146/annurev.pathol.4.110807.092135.
    1. Mennigen R, Bruewer M. Effect of probiotics on intestinal barrier function. Ann N Y Acad Sci. 2009;1165(1):183–189. doi: 10.1111/j.1749-6632.2009.04059.x.
    1. Yücel M, Kotan D, Çiftçi GG, Çiftçi I, Cikriklar H. Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci. 2016;20(5):930–936.
    1. Leung L, Cahill CM. TNF-alpha and neuropathic pain--a review. J Neuroinflammation. 2010;7(1):27. doi: 10.1186/1742-2094-7-27.
    1. Bruno PP, Carpino F, Carpino G, Zicari A. An overview on immune system and migraine. Eur Rev Med Pharmacol Sci. 2007;11(4):245–248.
    1. Perini F, D'Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, et al. Plasma cytokine levels in migraineurs and controls. Headache. 2005;45(7):926–931. doi: 10.1111/j.1526-4610.2005.05135.x.
    1. Dominguez C, Vieites-Prado A, Perez-Mato M, Sobrino T, Rodriguez-Osorio X, Lopez A, et al. Role of adipocytokines in the pathophysiology of migraine: a cross-sectional study. Cephalalgia. 2018;38(5):904–911. doi: 10.1177/0333102417720213.
    1. Martami F, Razeghi Jahromi S, Togha M, Ghorbani Z, Seifishahpar M, Saidpour A. The serum level of inflammatory markers in chronic and episodic migraine: a case-control study. Neurol Sci. 2018;39(10):1741–1749. doi: 10.1007/s10072-018-3493-0.
    1. Pathophysiology of Headaches From Molecule to Man. Paolo Martelletti RJ, editor: Springer, Cham; 2015
    1. Noseda R, Borsook D, Burstein R. Neuropeptides and neurotransmitters that modulate Thalamo-cortical pathways relevant to migraine headache. Headache. 2017;57(Suppl 2):97–111. doi: 10.1111/head.13083.
    1. Filpa V, Moro E, Protasoni M, Crema F, Frigo G, Giaroni C. Role of glutamatergic neurotransmission in the enteric nervous system and brain-gut axis in health and disease. Neuropharmacology. 2016;111:14–33. doi: 10.1016/j.neuropharm.2016.08.024.
    1. Holzer P, Reichmann F. Farzi AJN. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut–brain axis. 2012;46(6):261–274.
    1. Fischer JA, Born W. Novel peptides from the calcitonin gene: expression, receptors and biological function. Peptides. 1985;6(Suppl 3):265–271. doi: 10.1016/0196-9781(85)90384-5.
    1. Raybould HE. Mechanisms of CCK signaling from gut to brain. Curr Opin Pharmacol. 2007;7(6):570–574. doi: 10.1016/j.coph.2007.09.006.
    1. Ballaz S. The unappreciated roles of the cholecystokinin receptor CCK (1) in brain functioning. Rev Neurosci. 2017;28(6):573–585. doi: 10.1515/revneuro-2016-0088.
    1. Yao G, Han X, Hao T, Huang Q, Yu T. Effects of rizatriptan on the expression of calcitonin gene-related peptide and cholecystokinin in the periaqueductal gray of a rat migraine model. Neurosci Lett. 2015;587:29–34. doi: 10.1016/j.neulet.2014.12.021.
    1. O'Connor TP, van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci. 1988;8(7):2468–2476. doi: 10.1523/JNEUROSCI.08-07-02468.1988.
    1. Ferrara LA, Pacioni D, Di Fronzo V, Russo BF, Speranza E, Carlino V, et al. Low-lipid diet reduces frequency and severity of acute migraine attacks. Nutr Metab Cardiovasc Dis. 2015;25(4):370–375. doi: 10.1016/j.numecd.2014.12.006.
    1. Ornello R, Ripa P, Pistoia F, Degan D, Tiseo C, Carolei A, et al. Migraine and body mass index categories: a systematic review and meta-analysis of observational studies. J Headache Pain. 2015;16(1):27. doi: 10.1186/s10194-015-0510-z.
    1. Liou AP, Lu X, Sei Y, Zhao X, Pechhold S, Carrero RJ, et al. The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology. 2011;140(3):903–912. doi: 10.1053/j.gastro.2010.10.012.
    1. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. 2013;18(6):666–673. doi: 10.1038/mp.2012.77.
    1. Saulnier DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ, et al. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes. 2013;4(1):17–27. doi: 10.4161/gmic.22973.
    1. Foster JA, Neufeld K-AM. Gut–brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305–312. doi: 10.1016/j.tins.2013.01.005.
    1. Ghorbani Z, Nazari S, Etesam F, Nourimajd S, Ahmadpanah M, Razeghi JS. The effect of Synbiotic as an adjuvant therapy to fluoxetine in moderate depression: a randomized multicenter trial. Arch Neurosci. 2018;5(2):e60507. doi: 10.5812/archneurosci.60507.
    1. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009;106(10):3698–3703. doi: 10.1073/pnas.0812874106.
    1. Mittal R, Debs LH, Patel AP, Nguyen D, Patel K, O'Connor G, et al. Neurotransmitters: the critical modulators regulating gut-brain Axis. J Cell Physiol. 2017;232(9):2359–2372. doi: 10.1002/jcp.25518.
    1. Aamodt AH, Stovner LJ, Hagen K, Zwart JA. Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study Cephalalgia. 2008;28(2):144–151.
    1. Inaloo S, Dehghani SM, Hashemi SM, Heydari M, Heydari ST. Comorbidity of headache and functional constipation in children: a cross-sectional survey. Turk J Gastroenterol. 2014;25(5):508–511. doi: 10.5152/tjg.2014.6183.
    1. Meucci G, Radaelli F, Prada A, Bortoli A, Crotta S, Cerrato C, et al. Increased prevalence of migraine in patients with uninvestigated dyspepsia referred for open-access upper gastrointestinal endoscopy. Endoscopy. 2005;37(7):622–625. doi: 10.1055/s-2005-870251.
    1. Peşkersoy C, Peker Ş, Kaya A, Ünalp A, Gökay N. Evaluation of the relationship between migraine disorder andoral comorbidities: multicenter randomized clinical trial. Turkish journal of medical sciences. 2016;46(3):712–718. doi: 10.3906/sag-1412-71.
    1. Su J, Zhou XY, Zhang GX. Association between helicobacter pylori infection and migraine: a meta-analysis. World J Gastroenterol. 2014;20(40):14965–14972. doi: 10.3748/wjg.v20.i40.14965.
    1. Savi L, Ribaldone DG, Fagoonee S, Pellicano R. Is helicobacter pylori the infectious trigger for headache?: a review. Infectious disorders drug targets. 2013;13(5):313–317. doi: 10.2174/1871526513666131201125021.
    1. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 2006;6(1):26. doi: 10.1186/1471-230X-6-26.
    1. Chang FY, Lu CL. Irritable bowel syndrome and migraine: bystanders or partners? Journal of neurogastroenterology and motility. 2013;19(3):301–311. doi: 10.5056/jnm.2013.19.3.301.
    1. Gabrielli M, Cremonini F, Fiore G, Addolorato G, Padalino C, Candelli M, et al. Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol. 2003;98(3):625–629. doi: 10.1111/j.1572-0241.2003.07300.x.
    1. Ben-Or O, Zelnik N, Shaoul R, Pacht A, Lerner A. The neurologic profile of children and adolescents with inflammatory bowel disease. J Child Neurol. 2015;30(5):551–557. doi: 10.1177/0883073814521296.
    1. Oliveira GR, Teles BC, Brasil EF, Souza MH, Furtado LE, de Castro-Costa CM, et al. Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients. Inflamm Bowel Dis. 2008;14(3):389–395. doi: 10.1002/ibd.20304.
    1. Moisset X, Bommelaer G, Boube M, Ouchchane L, Goutte M, Dapoigny M, et al. Migraine prevalence in inflammatory bowel disease patients: a tertiary-care Centre cross-sectional study. Eur J Pain. 2017;21(9):1550–1560. doi: 10.1002/ejp.1056.
    1. Faraji F, Zarinfar N, Zanjani AT, Morteza A. The effect of helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. Pain physician. 2012;15(6):495–498.
    1. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology. 2005;64(10 suppl 2):S9–S15. doi: 10.1212/WNL.64.10_suppl_2.S9.
    1. Yang H, Zou Y, Zhang X. [Determination of serum calicotonin gene-related peptide in patients with duodenal ulcer infected with Helicobacter pylori]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University. 1999;24(3):273–4
    1. Munno I, Marinaro M, Bassi A, Cassiano MA, Causarano V, Centonze V. Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Headache. 2001;41(8):764–767. doi: 10.1046/j.1526-4610.2001.01140.x.
    1. Haeberle HA, Kubin M, Bamford KB, Garofalo R, Graham DY, El-Zaatari F, et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun. 1997;65(10):4229–4235. doi: 10.1128/IAI.65.10.4229-4235.1997.
    1. Windle HJ, Ang YS, Athie-Morales V, McManus R, Kelleher D. Human peripheral and gastric lymphocyte responses to helicobacter pylori NapA and AphC differ in infected and uninfected individuals. Gut. 2005;54(1):25–32. doi: 10.1136/gut.2003.025494.
    1. Hida N, Shimoyama T, Jr, Neville P, Dixon MF, Axon AT, Shimoyama T, Sr, et al. Increased expression of IL-10 and IL-12 (p40) mRNA in helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol. 1999;52(9):658–664. doi: 10.1136/jcp.52.9.658.
    1. Park JW, Cho YS, Lee SY, Kim ES, Cho H, Shin HE, et al. Concomitant functional gastrointestinal symptoms influence psychological status in Korean migraine patients. Gut and liver. 2013;7(6):668–674. doi: 10.5009/gnl.2013.7.6.668.
    1. Watson WC, Sullivan SN, Corke M, Rush D. Globus and headache: common symptoms of the irritable bowel syndrome. Can Med Assoc J. 1978;118(4):387–388.
    1. Lankarani KB, Akbari M, Tabrizi R. Association of Gastrointestinal Functional Disorders and Migraine Headache: a Population Base study. Middle East journal of digestive diseases. 2017;9(3):139–145. doi: 10.15171/mejdd.2017.64.
    1. Lau CI, Lin CC, Chen WH, Wang HC, Kao CH. Association between migraine and irritable bowel syndrome: a population-based retrospective cohort study. Eur J Neurol. 2014;21(9):1198–1204. doi: 10.1111/ene.12468.
    1. Martami F, Ghorbani Z, Abolhasani M, Togha M, Meysamie A, Sharifi A, et al. Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran. Neurol Sci. 2018;39(1):63–70. doi: 10.1007/s10072-017-3141-0.
    1. Zhou Q, Price DD, Callam CS, Woodruff MA, Verne GN. Effects of the N-methyl-D-aspartate receptor on temporal summation of second pain (wind-up) in irritable bowel syndrome. J Pain. 2011;12(2):297–303. doi: 10.1016/j.jpain.2010.09.002.
    1. Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther. 2004;20(10):1195–1203. doi: 10.1111/j.1365-2036.2004.02250.x.
    1. Li C, Yu S, Li H, Zhou J, Liu J, Tang W, et al. Clinical features and risk factors for irritable bowel syndrome in migraine patients. Pak J Med Sci. 2017;33(3):720–725.
    1. De Roos N, Giezenaar C, Rovers J, Witteman B, Smits M, Van Hemert S. The effects of the multispecies probiotic mixture ecologic® barrier on migraine: results of an open-label pilot study. Benef Microbes. 2015;6(5):641–646. doi: 10.3920/BM2015.0003.
    1. van Hemert S, Breedveld AC, Rovers JM, Vermeiden JP, Witteman BJ, Smits MG et al (2014) Migraine associated with gastrointestinal disorders: review of the literature and clinical implications. Front Neurol 5
    1. Aurora SK, Papapetropoulos S, Kori SH, Kedar A, Abell TL. Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications. Cephalalgia. 2013;33(6):408–415. doi: 10.1177/0333102412473371.
    1. Georgescu D, Reisz D, Gurban CV, Georgescu LA, Ionita I, Ancusa OE, et al. Migraine in young females with irritable bowel syndrome: still a challenge. Neuropsychiatr Dis Treat. 2018;14:21–28. doi: 10.2147/NDT.S144955.
    1. de Roos NM, van Hemert S, Rovers JMP, Smits MG, Witteman BJM. The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study. Eur J Clin Nutr. 2017;71(12):1455–1462. doi: 10.1038/ejcn.2017.57.
    1. Aydinlar EI, Dikmen PY, Tiftikci A, Saruc M, Aksu M, Gunsoy HG, et al. IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache. 2013;53(3):514–525. doi: 10.1111/j.1526-4610.2012.02296.x.
    1. Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004;141(8):1285–1293. doi: 10.1038/sj.bjp.0705762.
    1. Mulak A, Paradowski L. Migraine and irritable bowel syndrome. Neurol Neurochir Pol. 2005;39(4 Suppl 1):S55–S60.
    1. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther. 2010;31(1):35–46. doi: 10.1111/j.1365-2036.2009.04153.x.
    1. Gupta S, McCarson KE, Welch KM, Berman NE. Mechanisms of pain modulation by sex hormones in migraine. Headache. 2011;51(6):905–922. doi: 10.1111/j.1526-4610.2011.01908.x.
    1. Shannahan S, Leffler DA. Diagnosis and updates in celiac disease. Gastrointest Endosc Clin N Am. 2017;27(1):79–92. doi: 10.1016/j.giec.2016.08.011.
    1. Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823–836. doi: 10.1016/j.cgh.2017.06.037.
    1. Rani U, Imdad A, Beg M. Rare neurological manifestation of celiac disease. Case Rep Gastroenterol. 2015;9(2):200–205. doi: 10.1159/000431170.
    1. Aaron L, Torsten M, Patricia W. Autoimmunity in celiac disease: Extra-intestinal manifestations. Autoimmun Rev. 2019;18(3):241–246. doi: 10.1016/j.autrev.2018.09.010.
    1. Zis P, Julian T, Hadjivassiliou M. Headache associated with coeliac disease: a systematic review and meta-analysis. Nutrients. 2018;10(10):1445. doi: 10.3390/nu10101445.
    1. Dimitrova AK, Ungaro RC, Lebwohl B, Lewis SK, Tennyson CA, Green MW, et al. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache. 2013;53(2):344–355. doi: 10.1111/j.1526-4610.2012.02260.x.
    1. Burk K, Farecki ML, Lamprecht G, Roth G, Decker P, Weller M, et al. Neurological symptoms in patients with biopsy proven celiac disease. Movement disorders : official journal of the Movement Disorder Society. 2009;24(16):2358–2362.
    1. Lionetti E, Francavilla R, Maiuri L, Ruggieri M, Spina M, Pavone P, et al. Headache in pediatric patients with celiac disease and its prevalence as a diagnostic clue. J Pediatr Gastroenterol Nutr. 2009;49(2):202–207. doi: 10.1097/MPG.0b013e31818f6389.
    1. Diaconu G, Burlea M, Grigore I, Anton DT, Trandafir LM. Celiac disease with neurologic manifestations in children. Rev Med Chir Soc Med Nat Iasi. 2013;117(1):88–94.
    1. Battistella PA, Mattesi P, Casara GL, Carollo C, Condini A, Allegri F, et al. Bilateral cerebral occipital calcifications and migraine-like headache. Cephalalgia. 1987;7(2):125–129. doi: 10.1046/j.1468-2982.1987.0702125.x.
    1. Kopishinskaya SV, Gustov AV. Gluten migraine. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(8):13–17. doi: 10.17116/jnevro20151158113-17.
    1. Currie S, Hadjivassiliou M, Clark MJ, Sanders DS, Wilkinson ID, Griffiths PD, et al. Should we be ‘nervous’ about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurological opinion. J Neurol Neurosurg Psychiatry. 2012;83(12):1216–1221. doi: 10.1136/jnnp-2012-303281.
    1. La Mantia L, Pollo B, Savoiardo M, Costa A, Eoli M, Allegranza A, et al. Meningo-cortical calcifying angiomatosis and celiac disease. Clin Neurol Neurosurg. 1998;100(3):209–215. doi: 10.1016/S0303-8467(98)00029-8.
    1. D'Amico D, Rigamonti A, Spina L, Bianchi-Marzoli S, Vecchi M, Bussone G. Migraine, celiac disease, and cerebral calcifications: a new case. Headache. 2005;45(9):1263–1267. doi: 10.1111/j.1526-4610.2005.00253_2.x.
    1. Mormile R. Celiac disease and migraine: is there a common backstage? Int J Color Dis. 2014;29(12):1571. doi: 10.1007/s00384-014-1923-x.
    1. Cady RK, Farmer K, Dexter JK, Hall J. The bowel and migraine: update on celiac disease and irritable bowel syndrome. Curr Pain Headache Rep. 2012;16(3):278–286. doi: 10.1007/s11916-012-0258-y.
    1. Nenna R, Petrarca L, Verdecchia P, Florio M, Pietropaoli N, Mastrogiorgio G, et al. Celiac disease in a large cohort of children and adolescents with recurrent headache: a retrospective study. Dig Liver Dis. 2016;48(5):495–498. doi: 10.1016/j.dld.2015.12.015.
    1. Lionetto L, Negro A, Palmisani S, Gentile G, Del Fiore MR, Mercieri M, et al. Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs. 2012;17(3):393–406. doi: 10.1517/14728214.2012.709846.
    1. Razeghi Jahromi S, Ghorbani Z, Martelletti P, Lampl C, Togha M. Association of diet and headache. J Headache Pain. 2019;20(1):106. doi: 10.1186/s10194-019-1057-1.
    1. Serratrice J, Disdier P, de Roux C, Christides C, Weiller PJ. Migraine and coeliac disease. Headache. 1998;38(8):627–628. doi: 10.1046/j.1526-4610.1998.3808627.x.
    1. Hadjivassiliou M, Grunewald RA, Lawden M, Davies-Jones GA, Powell T, Smith CM. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology. 2001;56(3):385–388. doi: 10.1212/WNL.56.3.385.
    1. Chang S, Shen B. Classification and Reclassification of Inflammatory Bowel Diseases: From Clinical Perspective. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications: Elsevier; 2018. p. 17–34
    1. Chehel Cheraghi S, Ebrahimi Daryani N, Ghabaee M. A survey on migraine prevalence in patients with inflammatory bowel disease - a single Centre experience. Middle East journal of digestive diseases. 2016;8(4):282–288. doi: 10.15171/mejdd.2016.37.
    1. Doulberis M, Saleh C, Beyenburg S. Is there an association between migraine and gastrointestinal disorders? Journal of Clinical Neurology. 2017;13(3):215–226. doi: 10.3988/jcn.2017.13.3.215.
    1. Fellermann K, Steffen M, Stein J, Raedler A, Hamling J, Ludwig D, et al. Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease. Aliment Pharmacol Ther. 2000;14(2):171–176. doi: 10.1046/j.1365-2036.2000.00695.x.
    1. Dai YJ, Wang HY, Wang XJ, Kaye AD, Sun YH. Potential beneficial effects of probiotics on human migraine headache: a literature review. Pain physician. 2017;20(2):E251–E2E5.
    1. Plaza-Díaz Julio, Ruiz-Ojeda Francisco, Vilchez-Padial Laura, Gil Angel. Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases. Nutrients. 2017;9(6):555. doi: 10.3390/nu9060555.
    1. James Sensenig N, Jeffrey Marrongelle D, CCN MJS. T. Treatment of migraine with targeted nutrition focused on improved assimilation and elimination. Altern Med Rev. 2001;6(5):488–494.
    1. Martami F, Togha M, Seifishahpar M, Ghorbani Z, Ansari H, Karimi T, et al. The effects of a multispecies probiotic supplement on inflammatory markers and episodic and chronic migraine characteristics: a randomized double-blind controlled trial. Cephalalgia. 2019;39(7):841–853. doi: 10.1177/0333102418820102.
    1. Romeo MG, Romeo DM, Trovato L, Oliveri S, Palermo F, Cota F, et al. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol. 2011;31(1):63–69. doi: 10.1038/jp.2010.57.
    1. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Filannino A, Cavallo L, et al. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Investig. 2011;41(4):417–422. doi: 10.1111/j.1365-2362.2010.02425.x.
    1. de Roos N, van Hemert S, Rovers J, Smits M, Witteman B (2017) The effects of a multispecies probiotic on migraine and markers of intestinal permeability–results of a randomized placebo-controlled study. Eur J Clin Nutr
    1. Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014;11(8):497–505. doi: 10.1038/nrgastro.2014.40.
    1. Evcili G, Utku U, Ogun MN, Ozdemir G. Early and long period follow-up results of low glycemic index diet for migraine prophylaxis. Agri. 2018;30(1):8–11.
    1. Hildebrandt Marie A., Hoffmann Christian, Sherrill–Mix Scott A., Keilbaugh Sue A., Hamady Micah, Chen Ying–Yu, Knight Rob, Ahima Rexford S., Bushman Frederic, Wu Gary D. High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of Obesity. Gastroenterology. 2009;137(5):1716-1724.e2. doi: 10.1053/j.gastro.2009.08.042.
    1. Ramsden CE, Zamora D, Makriyannis A, Wood JT, Mann JD, Faurot KR, et al. Diet-induced changes in n-3-and n-6-derived endocannabinoids and reductions in headache pain and psychological distress. J Pain. 2015;16(8):707–716. doi: 10.1016/j.jpain.2015.04.007.
    1. Bic Z, Blix GG, Hopp HP, Leslie FM, Schell MJ. The influence of a low-fat diet on incidence and severity of migraine headaches. J Womens Health Gend Based Med. 1999;8(5):623–630. doi: 10.1089/jwh.1.1999.8.623.
    1. Bunner AE, Agarwal U, Gonzales JF, Valente F, Barnard ND. Nutrition intervention for migraine: a randomized crossover trial. J Headache Pain. 2014;15(1):69. doi: 10.1186/1129-2377-15-69.
    1. Bashir M, Prietl B, Tauschmann M, Mautner SI, Kump PK, Treiber G, et al. Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. Eur J Nutr. 2016;55(4):1479–1489. doi: 10.1007/s00394-015-0966-2.
    1. Togha M, Razeghi Jahromi S, Ghorbani Z, Martami F, Seifishahpar M. Serum vitamin D status in a Group of Migraine Patients Compared with Healthy Controls: a case-control study. Headache. 2018;58(10):1530–1540. doi: 10.1111/head.13423.
    1. Ghorbani Z, Togha M, Rafiee P, Ahmadi ZS, Rasekh Magham R, Haghighi S, et al. Vitamin D in migraine headache: a comprehensive review on literature. Neurol Sci. 2019;40(12):2459–2477. doi: 10.1007/s10072-019-04021-z.
    1. Nagpal R, Newman TM, Wang S, Jain S, Lovato JF, Yadav H. Obesity-linked gut microbiome Dysbiosis associated with derangements in gut permeability and intestinal cellular homeostasis independent of diet. J Diabetes Res. 2018;2018:3462092. doi: 10.1155/2018/3462092.
    1. Gelaye B, Sacco S, Brown WJ, Nitchie HL, Ornello R, Peterlin BL. Body composition status and the risk of migraine: a meta-analysis. Neurology. 2017;88(19):1795–1804. doi: 10.1212/WNL.0000000000003919.
    1. Bond DS, Vithiananthan S, Nash JM, Thomas JG, Wing RR. Improvement of migraine headaches in severely obese patients after bariatric surgery. Neurology. 2011;76(13):1135–1138. doi: 10.1212/WNL.0b013e318212ab1e.
    1. Novack V, Fuchs L, Lantsberg L, Kama S, Lahoud U, Horev A, et al. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. 2011;31(13):1336–1342. doi: 10.1177/0333102411413162.
    1. Jahromi SR, Abolhasani M, Ghorbani Z, Sadre-Jahani S, Alizadeh Z, Talebpour M, et al. Bariatric surgery promising in migraine control: a controlled trial on weight loss and its effect on migraine headache. Obes Surg. 2018;28(1):87–96. doi: 10.1007/s11695-017-2793-4.
    1. Verrotti A, Agostinelli S, D'Egidio C, Di Fonzo A, Carotenuto M, Parisi P, et al. Impact of a weight loss program on migraine in obese adolescents. Eur J Neurol. 2013;20(2):394–397. doi: 10.1111/j.1468-1331.2012.03771.x.
    1. Bond DS, Roth J, Nash JM, Wing RR. Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes Rev. 2011;12(5):e362–e371. doi: 10.1111/j.1467-789X.2010.00791.x.
    1. Laino D, Vitaliti G, Parisi P, Pavone P, Verrotti A, Lubrano R, et al. Headache, migraine and obesity: an overview on plausible links. J Biol Regul Homeost Agents. 2016;30(2):333–338.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel